ALNYLAM PHARMACEUTICALS, INC. - COM (ALNY)

Q2 2020 13F Portfolio Holders as of 6/30/2020

Type / Class
Equity / COM
Number of holders
365
Total Shares
111M
Shares change
+3.18M
Total reported value, excl. options
$16.5B
Value change
+$490M
Put/Call ratio
0.89
Number of buys
207
Number of sells
-131
Price
$148.11
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.